19P Stock Overview Provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Phreesia, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Phreesia Historical stock prices Current Share Price US$24.20 52 Week High US$26.80 52 Week Low US$16.60 Beta 0.99 1 Month Change 21.00% 3 Month Change 22.22% 1 Year Change 19.80% 3 Year Change -23.90% 5 Year Change -0.82% Change since IPO 14.39%
Recent News & Updates
Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year 2026 Dec 10
Phreesia, Inc. to Report Q3, 2025 Results on Dec 09, 2024 Nov 01
Second quarter 2025 earnings released: US$0.31 loss per share (vs US$0.68 loss in 2Q 2024) Sep 06
Phreesia, Inc. Maintains Revenue Guidance for the Fiscal Year 2025 Sep 05
General Counsel & Secretary recently sold €329k worth of stock Aug 30
Phreesia, Inc. to Report Q2, 2025 Results on Sep 04, 2024 Aug 01 See more updates
Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year 2026 Dec 10
Phreesia, Inc. to Report Q3, 2025 Results on Dec 09, 2024 Nov 01
Second quarter 2025 earnings released: US$0.31 loss per share (vs US$0.68 loss in 2Q 2024) Sep 06
Phreesia, Inc. Maintains Revenue Guidance for the Fiscal Year 2025 Sep 05
General Counsel & Secretary recently sold €329k worth of stock Aug 30
Phreesia, Inc. to Report Q2, 2025 Results on Sep 04, 2024 Aug 01
Now 26% overvalued Jul 12
First quarter 2025 earnings released: US$0.35 loss per share (vs US$0.70 loss in 1Q 2024) Jun 04
New minor risk - Share price stability Jun 04
Phreesia, Inc. Updates Earnings Guidance for the Year 2025 Jun 01
Phreesia, Inc. Updates Earnings Guidance for the Year 2025 May 31
Phreesia, Inc., Annual General Meeting, Jun 26, 2024 May 17
Phreesia, Inc. to Report Q1, 2025 Results on May 30, 2024 May 01
Co-Founder recently sold €251k worth of stock Apr 12
Phreesia Appoints Jack Callahan as Chief Technology Officer Mar 19
Full year 2024 earnings released: US$2.51 loss per share (vs US$3.36 loss in FY 2023) Mar 15
Phreesia, Inc. to Report Q4, 2024 Results on Mar 14, 2024 Feb 06
Co-Founder recently sold €1.5m worth of stock Jan 19
Third quarter 2024 earnings released: US$0.58 loss per share (vs US$0.76 loss in 3Q 2023) Dec 06
Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year 2024 and Fiscal Year 2025 Dec 06
Phreesia, Inc. to Report Q3, 2024 Results on Dec 05, 2023 Nov 02
Phreesia, Inc. Reaffirms Earnings Guidance for the Full Fiscal Year Ending January 31, 2024 and Fiscal Year 2025 Sep 08
Phreesia, Inc. Reaffirms Earnings Guidance for the Full Fiscal Year Ending January 31, 2024 and Fiscal Year 2025 Sep 07
Second quarter 2024 earnings released: US$0.68 loss per share (vs US$0.89 loss in 2Q 2023) Sep 07
New major risk - Revenue and earnings growth Aug 28
Phreesia, Inc. to Report Q2, 2024 Results on Sep 06, 2023 Aug 03
Phreesia, Inc. Appoints Lisa Egbuonu-Davis to Board of Directors Jul 14
Phreesia, Inc.(NYSE:PHR) dropped from Russell Small Cap Comp Value Index Jun 25
First quarter 2024 earnings released: US$0.70 loss per share (vs US$0.99 loss in 1Q 2023) Jun 01
Phreesia, Inc., Annual General Meeting, Jun 28, 2023 May 19
Full year 2023 earnings released: US$3.36 loss per share (vs US$2.37 loss in FY 2022) Mar 24
Phreesia, Inc. to Report Q4, 2023 Results on Mar 22, 2023 Feb 03
Third quarter 2023 earnings released: US$0.76 loss per share (vs US$0.71 loss in 3Q 2022) Dec 09
Phreesia, Inc. Provides Revenue Guidance for the Fiscal Year 2023 Dec 09
Insufficient new directors Nov 16
Phreesia, Inc. to Report Q3, 2023 Results on Dec 08, 2022 Oct 29
Second quarter 2023 earnings released: US$0.89 loss per share (vs US$0.48 loss in 2Q 2022) Sep 09
Phreesia, Inc. Updates Revenue Outlook for Fiscal Year 2023 Sep 08
Phreesia, Inc. to Report Q2, 2023 Results on Sep 07, 2022 Jul 30
First quarter 2023 earnings released: US$0.99 loss per share (vs US$0.24 loss in 1Q 2022) Jun 03
Phreesia, Inc. Provides Earning Guidance for Fiscal 2023 and 2025 Jun 03
Insufficient new directors Jun 02
Phreesia, Inc., Annual General Meeting, Jun 30, 2022 May 18
Phreesia, Inc. to Report Q1, 2023 Results on Jun 02, 2022 May 02
Full year 2022 earnings released: US$2.37 loss per share (vs US$0.69 loss in FY 2021) Apr 01 Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023 Mar 31
Phreesia, Inc. to Report Q4, 2022 Results on Mar 30, 2022 Mar 01
Phreesia, Inc. (NYSE:PHR) acquired Insignia Health, LLC from University of Oregon and others. Dec 15
Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat Dec 09 Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year 2023
Independent Director Cheryl Pegus has left the company Oct 05
Second quarter 2022 earnings released: US$0.48 loss per share (vs US$0.17 loss in 2Q 2021) Sep 03
Phreesia, Inc. Provides Revenue Guidance for the Fiscal Year 2022 Sep 02
Independent Director recently sold €252k worth of stock Jun 27
First quarter 2022 earnings released: US$0.24 loss per share (vs US$0.16 loss in 1Q 2021) Jun 05
Phreesia, Inc. Provides Revenue Guidance for the Fiscal Year 2022 Jun 04
Chief Financial Officer has left the company May 01
Full year 2021 earnings released: US$0.69 loss per share (vs US$4.50 loss in FY 2020) Apr 02
Phreesia, Inc. Provides Earnings Guidance for the Year Ending January 31, 2022 Apr 01
Phreesia, Inc. to Report Q4, 2021 Results on Mar 30, 2021 Feb 26
New 90-day high: €58.00 Feb 04
Insider recently sold €272k worth of stock Jan 23
New 90-day high: €47.80 Jan 13
Independent Director recently sold €1.1m worth of stock Dec 30
New 90-day high: €47.60 Dec 24
Insider recently sold €476k worth of stock Dec 22
Office Practicum and Phreesia Partner to Offer Seamlessly Integrated Patient Intake to Pediatric Practices Dec 12
Phreesia Announces Executive Changes Dec 10
Revenue beats expectations Dec 10
Third quarter 2021 earnings released: US$0.17 loss per share Dec 10
New 90-day high: €36.80 Dec 05
Phreesia, Inc. to Report Q3, 2021 Results on Dec 08, 2020 Nov 14
New 90-day high: €33.80 Nov 05
New 90-day high: €29.00 Oct 16
Phreesia, Inc. (NYSE:PHR) acquired The Family Caregiver and MedTrue from Geisinger Health System and Merck & Co., Inc. (NYSE:MRK). Oct 03
First half earnings released Sep 11
Phreesia, Inc. to Report Q2, 2021 Results on Sep 08, 2020 Aug 15
Phreesia, Inc.(NYSE:PHR) dropped from Russell 3000 Value Index Jul 03 Shareholder Returns 19P DE Healthcare Services DE Market 7D 0.8% -0.3% 0.7% 1Y 19.8% -18.5% 8.4%
See full shareholder returns
Return vs Market: 19P exceeded the German Market which returned 8.4% over the past year.
Price Volatility Is 19P's price volatile compared to industry and market? 19P volatility 19P Average Weekly Movement 9.2% Healthcare Services Industry Average Movement 6.3% Market Average Movement 4.9% 10% most volatile stocks in DE Market 12.0% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 19P's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 19P's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients’ mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks.
Show more Phreesia, Inc. Fundamentals Summary How do Phreesia's earnings and revenue compare to its market cap? 19P fundamental statistics Market cap €1.42b Earnings (TTM ) -€80.66m Revenue (TTM ) €394.77m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 19P income statement (TTM ) Revenue US$405.14m Cost of Revenue US$133.14m Gross Profit US$272.00m Other Expenses US$354.78m Earnings -US$82.78m
Last Reported Earnings
Oct 31, 2024
Earnings per share (EPS) -1.42 Gross Margin 67.14% Net Profit Margin -20.43% Debt/Equity Ratio 0.9%
How did 19P perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/02 05:38 End of Day Share Price 2025/01/02 00:00 Earnings 2024/10/31 Annual Earnings 2024/01/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Phreesia, Inc. is covered by 24 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Joseph Vruwink Baird Zhilin Long Berenberg Richard Close Canaccord Genuity
Show 21 more analysts 
